FGF10:typeIII epithelial mesenchymal transition and invasion in breast cancer cell lines
محل انتشار: سیزدهمین کنگره بین المللی سرطان پستان
سال انتشار: 1396
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 362
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED13_107
تاریخ نمایه سازی: 2 تیر 1397
چکیده مقاله:
Introduction: Epithelial mesenchymal transition (EMT) is a process related to the initiation of cell migration and metastasis. EMT categorized into three types: type 1 in gastrulation, 2 in wound healing and 3 in metastasis. Because of some similarities between procedures during gestational life and cancer, investigations about possible role of dysregulated molecules, which are responsible for organogenesis and growth of cells in fetus, on invasion and cancer metastasis is very important. FGF10 is a protein in type I EMT. There are some evidences showing correlations between the expressing levels of FGF10 and invasion of cancer cells. this study show the effect of these cell-line behaviors is directly related to FGF10 through regulation of EMT mechanisms in various types of signaling pathways.Methods: Gene regulation by siRNA and recombinant protein. Western blot, MTT, Colony agar, Migration, Wound healing and Apoptosis assay. Real Time PCR.Results: Positive effect of FGF10 on proliferation, tumorgenesis and wound healing ability of cells. Invasion and migration ability of cells dependents on FGF10 production. Apoptosis is decreased under FGF10 protein. EMT induction factors change under FGF10 effects and initiate EMT program. Conclusion: Our data suggested that if FGF10 is dysregulated in cancer, it can act as a wild agent involving cell proliferation, immortality, tumorigenesis and EMT followed by invasion and metastasis.
نویسندگان
Ali kian saei
IBB, University of Tehran
Hossein Riazi
IBB, University of Tehran
Reza Shirkoohi
Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences